The Correlation of Congenital CMV Infection and the Outcome of Cochlear Implantation
Open Access
- 1 May 2021
- journal article
- research article
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 17 (3) , 190-194
Abstract
OBJECTIVES: Cytomegalovirus (CMV) infection is the most common intrauterine viral infection, affecting approximately 0.5-2.5% of all live births in the world. The majority of patients are asymptomatic at birth, but several clinical consequences are related to this infection, including neurosensory hearing loss. The cochlear implant is the treatment of choice when the hearing loss is severe to profound. Compare the audiological evolution after cochlear implant surgery in a group of children born with congenital CMV infection compared to a control group of children born with a genetic cause of congenital hearing loss. Determine prognostic factors predicting the outcome of patients with congenital hearing loss secondary to CMV infection following cochlear implantation. METHODS: Our retrospective study aimed at the analysis of 48 patients with cochlear implants, 25 patients with congenital CMV, and 23 patients in the control group with cochlear cause of hearing loss, who were matched for gender, age of onset, and type of hearing loss. Primary outcomes are auditory evolution with the Infant-Toddler Meaningful Auditory Integration Scale (IT-MAIS) and the multimedia audiologic test (MAT). Secondary outcomes are evaluation of prognostic factors for the CMV group, like MRI severity sign, antiviral treatment, and neuropsychological disorder. RESULTS: For the MAT, the results are 73.9% in the CMV group and 81.6% in the control group (P = .03). For the IT-MAIS, the results are 29.3/40 in the CMV group and 29.2/40 in the control group (P = .96). In the CMV group, the children treated with antiviral treatment have IT-MAIS difference of 28.5/40 compared to 23.2/40 for the children without antiviral treatment (P = .03). We found a little trend in the correlation between auditory results and the presence of neuropsychological disorders, but there are no statistically significant results. CONCLUSION: The results of the audiological tests in the CMV group allow an adequate functioning, even if lower than in the control group. There are benefits of implantation in patients with CMV, and audiological results are still satisfactory for proper functioning. CMV patients enjoy superior results in terms of hearing, with antiviral treatment. Cite this article as: H. Bolduc S, Bussières R, Philippon D, Côté M. The correlation of congenital CMV infection and the outcome of cochlear implantation. J Int Adv Otol. 2021;17(3):190-194.Keywords
This publication has 17 references indexed in Scilit:
- Cochlear implantation in children with congenital cytomegalovirus infection accompanied by psycho-neurological disordersActa Oto-Laryngologica, 2012
- Cochlear Implantation in Children With Congenital Cytomegalovirus InfectionOtology & Neurotology, 2009
- Rehabilitation and outcome of severe profound deafness in a group of 16 infants affected by congenital cytomegalovirus infectionEuropean Archives of Oto-Rhino-Laryngology, 2009
- Cochlear Implant in Children with Asymptomatic Congenital Cytomegalovirus InfectionAudiology and Neurotology, 2008
- Effect on hearing of ganciclovir therapy for asymptomatic congenital cytomegalovirus infection: four to 10 year follow upThe Journal of Laryngology & Otology, 2008
- Effects of Cytomegalovirus (CMV) Related Deafness on Pediatric Cochlear Implant OutcomesOtolaryngology–Head and Neck Surgery, 2005
- Cochlear Implantation in Children Deafened by Cytomegalovirus: Speech Perception and Speech Intelligibility OutcomesOtology & Neurotology, 2004
- Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infectionThe Journal of Pediatrics, 2001
- Congenital cytomegalovirus infection and neonatal auditory screeningThe Journal of Pediatrics, 1993
- Congenital Cytomegalovirus Disease — 20 Years Is Long EnoughNew England Journal of Medicine, 1992